HNGF6A

Modify Date: 2025-08-25 12:14:53

HNGF6A structure	Common Name	HNGF6A
	CAS Number	1093111-54-6	Molecular Weight	2581.11
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₁₁₂H₁₉₈N₃₄O₃₁S₂	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of HNGF6A

HNGF6A is a humanin analogue. HNGF6A increases glucose-stimulated insulin secretion and glucose metabolism, and has the potential for diabetes research. HNGF6A inhibits of ROS production during oxidative stress. HNGF6A can prevent endothelial dysfunction and atherosclerosis in vivo[1][2].

Name	HNGF6A

Description	HNGF6A is a humanin analogue. HNGF6A increases glucose-stimulated insulin secretion and glucose metabolism, and has the potential for diabetes research. HNGF6A inhibits of ROS production during oxidative stress. HNGF6A can prevent endothelial dysfunction and atherosclerosis in vivo[1][2].
Related Catalog	Research Areas >> Cardiovascular Disease Research Areas >> Metabolic Disease Research Areas >> Neurological Disease
References	[1]. Yun K Oh, et al. Humanin preserves endothelial function and prevents atherosclerotic plaque progression in hypercholesterolemic ApoE deficient mice. Atherosclerosis. 2011 Nov;219(1):65-73. [2]. Regina Kuliawat, et al. Potent humanin analog increases glucose-stimulated insulin secretion through enhanced metabolism in the β cell. FASEB J. 2013 Dec;27(12):4890-8.

Description

Related Catalog

Research Areas >> Cardiovascular Disease

Research Areas >> Metabolic Disease

Research Areas >> Neurological Disease

References

[1]. Yun K Oh, et al. Humanin preserves endothelial function and prevents atherosclerotic plaque progression in hypercholesterolemic ApoE deficient mice. Atherosclerosis. 2011 Nov;219(1):65-73.

[2]. Regina Kuliawat, et al. Potent humanin analog increases glucose-stimulated insulin secretion through enhanced metabolism in the β cell. FASEB J. 2013 Dec;27(12):4890-8.